Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 30, 2023
Event: Entry into a Material Definitive Agreement involving a private placement of securities to fund operations and support a planned business combination with SEP Acquisition Corp. ("SEPA").
Key Financial Metrics and Transaction Details
- Proceeds Received: $1.8 million in cash at closing.
- Debt Instrument: Future advance convertible promissory notes with an aggregate principal amount of approximately $1.9 million.
- Interest Rate: 15% per annum on outstanding principal.
- Conversion Price: $0.04 per share (subject to adjustment, with a floor of $0.01).
- Warrants Issued:
- 46.5 million "First Warrants" with an exercise price of $0.067 per share.
- 46.5 million "Second Warrants" with an exercise price of $0.04 per share.
- Term: 5 years.
- Subordination: Rights of purchasers are subordinate to NH Expansion Credit Fund Holdings LP.
Material Changes and Agreements
The filing details a significant capital raise structured to facilitate a pending merger. Key changes include:
- Private Placement Closing: Completed on December 30, 2023, with proceeds of $1.8 million.
- Waivers Granted: Purchasers waived obligations for a reverse stock split, share reserve amendments, and immediate registration of securities through December 31, 2024.
- Merger Exchange Agreement: Purchasers agreed to exchange Notes and Warrants for common stock immediately prior to the closing of the business combination with SEPA.
- Notes exchanged at $0.04 per share.
- $0.04 Warrants exchanged at 0.9 shares per warrant.
- $0.067 Warrants exchanged at 0.85 shares per warrant.
- Registration Rights: Company agreed to file a registration statement within 60 days and make it effective within 180 days.
Outlook, Risks, and Contingencies
Outlook: The transaction is contingent upon the successful closing of the merger with SEPA. The company anticipates exchanging the debt and warrants for equity in the combined entity.
Risks and Contingencies:
- Merger Failure: The transaction depends on stockholder approvals and regulatory clearances.
- Liquidity Requirement: SEPA must have at least $12.0 million at closing from unredeemed stock and private placement proceeds.
- Listing Risk: Uncertainty regarding the ability to maintain a Nasdaq listing post-transaction.
- Forward-Looking Statements: Actual results may differ materially due to economic factors, legal changes, or termination of the Merger Agreement.
Investor Verification Checklist
- Verify the status of the merger agreement with SEP Acquisition Corp. and the $12.0 million liquidity requirement.
- Confirm the dilution impact of the 93 million warrants and the conversion of $1.9 million in notes into common stock.
- Review the subordination agreement with NH Expansion Credit Fund Holdings LP to understand debt hierarchy.
- Monitor the filing of the Form S-4 and proxy statements for the proposed merger.
- Check for any updates on the reverse stock split waiver expiration (December 31, 2024).